H1 Presentation and Q&A
How does this Q&A work:
This company invites all interested, both current investors and potential investors to participate in this event, ask questions directly on this page before the event starts and upvote those questions you would like addressed.
The company will address as many questions as possible, and focus on those questions most wanted by investors.
Speakers at this event:
8 Questions
Aug. 27, 2024
Can we expect any milestones here in H2 2024 or potentially in H1 2025?
Aug. 27, 2024
You have an exciting project. Do you have plans to actively increase investor awareness?
Aug. 27, 2024
As a result of Pila Pharma's liquidity forecasts and cash flow analyses, how long is there liquidity to finance the ongoing investigation of the project in relation to phase 2?
In relation to the answer above, when is a new necessary capital acquisition from the market expected for Pila Pharma to be able to continue the test studies?
Aug. 26, 2024
When do you expect to be able to announce your next test results?
Aug. 26, 2024
Can you explain why Pila Pharma was one of the most traded non-danish companies on Nordnet last time?
Aug. 26, 2024
What therapeutics in the development/approval pipeline are competitive threats to Pila Pharma?
Aug. 21, 2024
How long do you believe the 10 SEKm in capital increase will take you? What is the timeframe for when you need to raise more capital and can we expect to have new trial results at that point in time?
Aug. 21, 2024
Can you provide som more information on the partnership with Lindus Health. Is there any financial impact from the partnership or how do you expect it to impact Pila Pharma positively?